Topics:

Rheumatic Diseases

Dermatomyositis, DVT, and D-Dimer

A man with amyopathic dermatomyositis eventually turned up in the ER with PE and DVT. Could his D-Dimer levels have been a tip-off for more aggressive treatment.

Rheumatic Diseases

medication risks

When it comes to discussing medication risks, a new study shows, rheumatologists and their patients are speaking different languages. The article reveals how doctors may be sending messages they don't intend.

prior authorization

Prior authorizations have begun to spread pandemic-like from high-cost biologics to treatments used routinely in rheumatology. The time burden on rheumatologists is insupportable, contends the author, who says it's time to take action.

Anticoagulants don't help even the rare patients with Behçet disease who present with vascular symptoms, a retrospective study shows. Persistence with other treatments, though, is imperative.

Antinuclear antibody testing and DEXA both appear on a new Canadian list of rheumatology tests to avoid and on a similar 2013 list from the American College of Rheumatology. There are interesting differences in the other 3 choices.

Patient age and platelet count can inform the need for temporal artery biopsy in diagnosing giant cell arteritis, a retrospective study suggests.

sarcoidosis

A dermatologist has referred a patient who presented with a nodule on the edge of her ear. Can you guess the unusual diagnosis that led to the referral?

Oral etidronate, IV pamidronate, and then zoledronate caused bone markers to normalize in this 80-year-old woman—temporarily. What’s going on? Answer this and questions on 3 other topics in this week’s quiz.

Pages

Subscribe to Rheumatic Diseases on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.